Alwin Krämer

机构：German Cancer Research Center, Heidelberg University · ORCID：0000-0001-8232-9982

发表论文 298 篇 · 总被引 13402 次 · h-index 55

代表论文

• Tumour mutational burden: clinical utility, challenges and emerging improvements (2024 · Nature Reviews Clinical Oncology · 被引 154)
• Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study (2024 · The Lancet · 被引 84)
• Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype (2024 · Nature Genetics · 被引 41)
• Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial (2023 · Nature Communications · 被引 41)
• Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1 , GATA2 , and DDX41 (2023 · Blood Advances · 被引 41)
• Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary (2024 · Clinical Chemistry · 被引 10)